Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2017 10:29 ET | Source: VBL Therapeutics

VBL Therapeutics to Report Third Quarter 2017 Results on November 14

TEL AVIV, Israel, Nov. 07, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
November 06, 2017 07:00 ET | Source: VBL Therapeutics

VBL Therapeutics and NanoCarrier Co., Ltd. Sign Exclusive Agreement for VB-111 in Japan

Agreement includes $15 million up front, potential milestones payments of more than $100 million, as well as tiered high-teen royalties NanoCarrier receives exclusive rights to VB-111 in...
October 23, 2017 08:05 ET | Source: VBL Therapeutics

VBL Therapeutics Celebrates Opening of its New Gene Therapy Manufacturing Plant and Company Headquarters

TEL AVIV, Israel, Oct. 23, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT) announced today the opening of its new gene therapy manufacturing plant in Modiin, Israel. This plant will be the...
October 20, 2017 07:00 ET | Source: VBL Therapeutics

VBL Therapeutics Announces Orphan Drug Designation for VB-111 in Europe

New EMA orphan approval for Ovarian Cancer complements previously granted VB-111 orphan status for Glioblastoma in the US and Europe TEL AVIV, Israel, Oct. 20, 2017 (GLOBE NEWSWIRE) -- VBL...
October 02, 2017 07:00 ET | Source: VBL Therapeutics

VBL Therapeutics Announces Positive Outcome in the Third and Final DSMC Review of Phase 3 GLOBE Trial Investigating VB-111 in Recurrent GBM

Top-line data expected in Q1 2018 TEL AVIV, Israel, Oct. 02, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), today announced that the independent Data Safety Monitoring Committee (DSMC)...
September 28, 2017 07:00 ET | Source: VBL Therapeutics

VBL Therapeutics to Present at the Chardan Gene Therapy Conference

TEL AVIV, Israel, Sept. 28, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
September 14, 2017 08:00 ET | Source: VBL Therapeutics

VBL Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference on September 26th in New York

TEL AVIV, Israel, Sept. 14, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
August 28, 2017 08:00 ET | Source: VBL Therapeutics

VBL Therapeutics to Present at the Rodman & Renshaw Global Investment Conference in New York on September 10-12, 2017

TEL AVIV, Israel, Aug. 28, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...
August 14, 2017 07:00 ET | Source: VBL Therapeutics

VBL Therapeutics Announces Second Quarter 2017 Financial Results

TEL AVIV, Israel, Aug. 14, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), announced financial results for the three and six months ended June 30, 2017 and provided a corporate update. ...
August 02, 2017 08:00 ET | Source: VBL Therapeutics

VBL Therapeutics to Report Second Quarter 2017 Results on August 14

TEL AVIV, Israel, Aug. 02, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...